Interestingly, we found that ALS-related FUS mutants did not alter either the ability of the disease proteins to interact with PRMT1 or PRMT8 or the overall methylation status of the proteins, indicating that substitutions of arginine residues in the carboxy-terminal portion of FUS does not compromise arginine methylation. This evidence concerns the gene PRMT8 and amyotrophic lateral sclerosis.